The value proposition of investigator-initiated clinical trials conducted by networks

dc.contributor.authorTate, R.
dc.contributor.authorBritton, E.
dc.contributor.authorWebb, S.
dc.contributor.authorRamage, C.
dc.contributor.authorBernhardt, J.
dc.contributor.authorCass, A.
dc.contributor.authorFrench, C.J.
dc.contributor.authorGroom, K.
dc.contributor.authorHerkes, R.
dc.contributor.authorKatz, C.
dc.contributor.authorMol, B.W.
dc.contributor.authorSimes, R.J.
dc.contributor.authorSonderlund, N.
dc.contributor.authorButcher, B.E.
dc.contributor.authorZalcberg, J.R.
dc.date.issued2021
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityRhiannon Tate, Emma Britton, Steve Webb, Charlotte Ramage, Julie Bernhardt ... Bernardus Mol ... et al.
dc.identifier.citationMedical Journal of Australia, 2021; 214(4):159-161
dc.identifier.doi10.5694/mja2.50935
dc.identifier.issn0025-729X
dc.identifier.issn1326-5377
dc.identifier.orcidMol, B.W. [0000-0001-6887-0262] [0000-0001-8337-550X]
dc.identifier.urihttp://hdl.handle.net/2440/130937
dc.language.isoen
dc.publisherAustralasian Medical Publishing Company
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1176437
dc.rights© 2021 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
dc.source.urihttps://doi.org/10.5694/mja2.50935
dc.subjectClinical trials as topic; cost-benefit analysis; economics; medical
dc.titleThe value proposition of investigator-initiated clinical trials conducted by networks
dc.typeJournal article
pubs.publication-statusPublished

Files